Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rheum palmatum root is the dried root of the plant Rheum palmatum L., commonly known as Chinese rhubarb. It has a long history of use in traditional Chinese medicine and is primarily used as a stimulant laxative for the short-term treatment of occasional constipation. The main active constituents are anthraquinone derivatives (such as emodin and rhein), which stimulate bowel movements by increasing peristalsis and altering water and salt absorption in the intestines. At lower doses, tannins present in the root can have an astringent effect; at higher doses, hydrolyzed metabolites produce a purgative effect. Other reported uses include management of gastrointestinal disorders (such as diarrhea or indigestion), liver diseases, menstrual cramps, symptoms of menopause (due to estrogenic compounds like lindleyin), inflammation (anti-inflammatory effects from emodin and other phenolics), hyperlipidemia, cancer adjunctive therapy (preclinical evidence only), pancreatitis symptom relief, and topical application for oral mucosa inflammation. However, robust clinical evidence supports only its use for constipation[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rheum palmatum root.